Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-027581

Chief Operating Officer gave up 2,624 shares (to pay taxes)

  • Chief Operating Officer acquired 8,953 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2023-09-30 Option exercise +8,953 48,540 D
Cittadine Andrew Chief Operating Officer 2023-09-30 Shares withheld for taxes −2,624 $0.62 $1,627 45,916 D
Derivatives
Cittadine Andrew Chief Operating Officer 2023-09-30 Option exercise · Restricted Stock Units −8,953 100,127 D
Loading xslF345X05/rdgdoc.xml…